GN
Getinge AB (publ)
GNGBY · OTC
$25.18 -1.45% (-$0.37)
1M +0.16%
Market Cap 65.7B kr
P/E Ratio 24.64x
Div. Yield 2.03%
ROE 8.86%
Bulios Fair Price
$25.51
1.3% upside
Current Price
$25.18
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GNGBY is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
71 /100
Cheap P/FCF 17.38x
P/S 1.93x
P/B 2.12x
Growth
35 /100
Stable Rev. growth 7.32%
FCF growth 3.56%
Book val. growth 0.68%
Profitability
67 /100
Strong Net margin 7.82%
Op. margin 13.04%
FCF margin 11.09%
Quality
41 /100
Average ROE 8.86%
ROA 4.65%
Asset turnover 0.59x
Debt
79 /100
Low Current ratio 1.31x
Int. coverage 7.41x
Net debt/EBITDA 1.37x
Stability
87 /100
Stable Rev. volatility 6.14%
EPS volatility 35.23%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GNGBY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mattias Perjos
Employees
12,118
Headquarters
Gothenburg
Upcoming events
20 OCT
Earnings
Upcoming earnings report